Understanding CGM Metrics

Experts discuss the relative value of different continuous glucose monitoring (CGM) metrics (glucose management indicator [GMI], time in range, glucose variability) in assessing glycemic control and how these outcomes vary across different patient populations.

EP: 1.CGM: Redefining Type 2 Diabetes Management

EP: 2.Key Benefits of CGM Technology

EP: 3.CGM's Impact on Clinical Inertia

EP: 4.CGM vs Traditional Monitoring

Now Viewing

EP: 5.Understanding CGM Metrics

EP: 6.Health Care System Integration

EP: 7.CGM Coverage and Access

EP: 8.Implementation Barriers

EP: 9.Overcoming Access Challenges

EP: 10.Adoption Strategies

EP: 11.The Metro Nashville Public Schools Initiative

EP: 12.Health Care Quality Impact

EP: 13.Population Outcomes and Return on Value With CGMs

EP: 14.Long-Term Outcomes Assessment

EP: 15.Closing Perspectives

Video content above is prompted by the following:

Please discuss the relative value of different CGM metrics (GMI, Ttime in Rrange, glucose variability) in assessing glycemic control.

How do these outcomes vary across different patient populations?

Related Videos

Related Content

Advertisement

July 22nd 2025

States Target Medicaid QIPs to Improve Health Access, Outcomes

Pearl Steinzor

Mental health, care of acute and chronic conditions, primary care access and prevention, and maternal and perinatal health were identified as key focus areas among a majority of states.

July 8th 2025

Managed Care Cast News Roundup: July 8, 2025

Giuliana Grossi

Medical societies challenge HHS Secretary Robert F. Kennedy Jr's COVID-19 vaccine rollbacks, and more news updates from the week.

July 21st 2025

Social Determinants of Health Linked to Congestive Heart Failure Deaths

Sabrina McCrear

Social determinants of health significantly increased mortality risks in patients with congestive heart failure, highlighting urgent care needs.

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

July 18th 2025

Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025

Maggie L. Shaw

These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.

July 18th 2025

CGT Access Model Aims to Expand Access to Sickle Cell Treatments

Rose McNulty

States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.

Related Content

Advertisement

July 22nd 2025

States Target Medicaid QIPs to Improve Health Access, Outcomes

Pearl Steinzor

Mental health, care of acute and chronic conditions, primary care access and prevention, and maternal and perinatal health were identified as key focus areas among a majority of states.

July 8th 2025

Managed Care Cast News Roundup: July 8, 2025

Giuliana Grossi

Medical societies challenge HHS Secretary Robert F. Kennedy Jr's COVID-19 vaccine rollbacks, and more news updates from the week.

July 21st 2025

Social Determinants of Health Linked to Congestive Heart Failure Deaths

Sabrina McCrear

Social determinants of health significantly increased mortality risks in patients with congestive heart failure, highlighting urgent care needs.

July 1st 2025

Why Collaborative Care Is the Path Forward for Mental Health Care: Anna Bobb, MPH

Giuliana Grossi Anna Bobb, MPH

Explore how the Collaborative Care Model enhances mental health access in this episode featuring Anna Bobb, MPH, executive director of the Path Forward coalition.

July 18th 2025

Best of Managed Care Cast: Top 5 Episodes From the First Half of 2025

Maggie L. Shaw

These interviews are the top episodes, by listens, from among the 21 podcast episodes The American Journal of Managed Care® produced over the first half of 2025. Give them all another listen, and perhaps learn something new.

July 18th 2025

CGT Access Model Aims to Expand Access to Sickle Cell Treatments

Rose McNulty

States participating in the Cell and Gene Therapy (CGT) Access Model will be testing outcomes-based payments for sickle cell disease treatments.